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The 1H and 13C NMR data of a series of epoxy- and epidioxy-bridged tetrahydropyran 
derivatives containing the same basic carbon skeleton, are reported. 13C NMR spectroscopy was 
shown to be useful for structural determination of both substructures allowing facile distinction 
of otherwise similar compounds. 
 






As part of our investigations on the photochemical reactivity of dienone systems, we have 
established an easy approach for the preparation of a series of bridged unsaturated 1,2,4-
trioxanes 1a–g by irradiation of the corresponding β-ionone derivatives in the presence of 
oxygen.1,2 Due to their peroxidic nature, analogous to the pharmacophore of the potent 
antimalarial compound artemisinin, 1,2,4-trioxanic compounds have been the focus of great 
synthetic activity and several aspects of their fundamental chemical reactivity are currently under 
investigation.3,4 
During our studies directed to identifying mild and synthetically useful transformations of 1,5 
heterogeneous catalytic hydrogenation conditions were used to examine the chemoselectivity of 
the reduction process and to test primarily peroxy bond compatibility. The reduction of 1a–g 
affords products containing the 2,3,5-trioxabicyclo[2.2.2]octane and 2,7-
dioxabicyclo[2.2.1]heptane units 2a–g and 3a–g, respectively, that can not readily be 
distinguished by means of spectroscopic techniques. As far as we know, there are no reports in 
the literature concerning NMR spectral studies for the two sets of oxygen-bridged pyran 
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derivatives having similar 1H and 13C spectra. Herein we report the characterization of the 




Results and Discussion 
 
The reduction of 1a–g using platinum oxide as catalyst in ethyl acetate under atmospheric 
pressure of hydrogen furnished a set of compounds containing the 2,3,5-
trioxabicyclo[2.2.2]octane and 2,7-dioxabicyclo[2.2.1]heptane units, 2a–g and 3a–g, respectively 
(Scheme 1). Depending on reaction conditions (mainly amount of catalyst and reaction times) 
and on substrate structure, reaction products consisted of mixtures of compounds 2 and 3, or 
solely the over-reduced products 3. In order to study the chemoselectivity of the reaction6,7 and 
due to the fact that 1H and 13C spectral data for both compounds are too similar, we initially 
faced the problem of identifying the structures unambiguously. After chromatographic 
separation, compounds 2 and 3 were isolated in pure form and an exhaustive NMR study was 
carried out in order to attempt the complete 1H and 13C signal assignments and to ascertain 
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Scheme 1. Hydrogenation of unsaturated 1,2,4-trioxanes derived from β-ionone. 
 
1H NMR assignments for compounds 2a–g and 3a–g were not straightforward because of 
overlapping in the aliphatic region, making determination of any correlation between chemical 
shifts and epoxy or epidioxy bridged structures problematic.  
Comparison of the similarities and differences in the 13C NMR data between 1, 2 and 3 
revealed several trends leading to useful generalizations. During our study, we could realize that 
the 13C chemical shift values of the oxygenated quaternary carbons change in a regular manner 
on going from the unsaturated 1 to the saturated systems 2. The changes involved were low-
frequency shift (above 1 ppm) of C-1 signal, high-frequency shift (above 2 ppm) for C-8, while 
resonance of C-6 remained unaltered. 
On the other hand, a similar analysis of the 13C data for the [2.2.2] and [2.2.1] oxacyclic 
series 2 and 3, showed significant differences. All carbons corresponding to the pyran skeleton 
[C-1, C-6, C-8, C-9(12) and C-10(11)] experienced a high-frequency shift on going from the 
epidioxy-bridged systems to the contracted epoxy-bridged unit. The resonance position of 
carbons C-1, C-8, C-9(12) and C-10(11) in 3 appeared shifted to higher frequencies by 5 to 11 
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ppm while for C-6 differences were small (ca. 3 ppm) if compared with the same carbons in 2 
(see Table 1). Particularly, the 13C chemical shifts of the oxa-bridge-bearing carbons C-1 and C-8 
can be used to distinguish the [2.2.2] series 2 from the [2.2.1] series 3 without any further 
analysis of other spectral data. These two 13C signal values experienced a high-frequency shift 
(90–95 vs. 80–85 ppm for C-1 and 107–108 vs. 96–98 ppm for C-8) comparing the contracted 
system 3 with 2. This simple rule facilitated our work aimed at finding reaction conditions for 
chemoselective control.  
 
Table 1. ∆δc values (in ppm) of carbons 1, 6, 8, 9(12) and 10(11) for series 3 and 2a 
Compounds C-1 C-6 C-8 C-9(12) C-10(11) 
3a, 2a 11.4 3.6 10.7 7.4 5.3 
3b, 2b 12.1 3.0 10.7 7.1 5.2 
3c, 2c 11.7 4.6 11.2 7.5 5.5 
3d, 2d 12.4 2.7 11.3 7.3 5.0 
3e, 2e 11.8 4.3 11.5 7.5 5.4 
3f, 2f 11.5 3.2 9.8 7.7 4.5 
3g, 2g 11.2 3.3 8.5 7.3 4.3 
a∆δ = δc 3 – δc 2 
 
The nature and stereochemistry of the substituents at C-5 appeared to have no influence upon 
the chemical shift of those diagnostic signals. Considering that we have also observed a slight 
effect on position 1 and 8 by saturation of the C-C double bond on going from 1 to 2, the large 
deshielding effect observed in the chemical shifts of C-1 and C-8 carbon atoms in compounds 3 
probably results from the enhancement of the annular strain due to the contraction of the 
oxygenated bridge,8 following the same trend as in the carbocyclic frameworks being the 
norbornyl system more strained than the bicyclo[2.2.2]octyl unit.9 
For all the examples shown the trend is uniform, variations of chemical shifts were large 
enough (ca. 10 ppm) and the corresponding signals were clearly separated from others in the 
spectrum so that both systems 2 and 3 could be easily distinguished providing a diagnostic 
method for the structural elucidation of epoxy and epidioxy bridged pyran systems by 
application of conventional one-dimensional 13C NMR. The results disclosed herein may offer a 






General. NMR spectra were recorded in chloroform-d at room temperature at 7.05 Tesla using a 
300.13 MHz Fourier transform NMR spectrometer (Bruker Avance II) equipped with a 5 mm 
multinuclear BBO probehead with a Z-shielded gradient. For the 1H NMR analyses, 16 transients 
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were acquired with a 1 s relaxation delay, using 16 k data points. The 90º pulse duration was of 
10 µs and the spectral width was 3000 Hz. The 13C NMR and DEPT spectra were obtained with a 
spectral width of 18029 Hz, using 32 k data points. Their 90º pulse duration was of 8 µs. The 
pulse programs for the 2D experiments (HSQC and HMBC) were the standard sequences taken 
from the Bruker software library. Chemical shifts for 1H NMR spectra are reported in parts per 
million relative to the signal of tetramethylsilane at 0 ppm (internal standard). Chemical shifts 
for 13C NMR spectra are reported in parts per million relative to the center line of the CDCl3 
triplet at 76.9 ppm. 
For all compounds, assignment of C-6, C-8 and C-2 methyl groups were made by analysis of 
their HSQC and HMBC 2D experiments except for compounds 3a, 2g, 1c, 1f and 1g. For the 
latter, assignments were made by analogy with other compounds of the same series. For all 
compounds, stereo-differentiation between C-2 methyl groups (axial and equatorial) was made 
by analysis of NOE experiments (NOE between C-6 Me and C-2 Meax; or absence of NOE 
between C-2 Meeq and C-6 Me) except for compounds 3a, 2g, 1g, 1c and 1e. In this case, 
assignments were made by analogy with other compounds of the same series based on proton 
chemical shifts of methyl groups. 
 
2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodec-11-ene (1a). 1H NMR (CDCl3, 300 
MHz): δ = 6.53 (d AB, J = 8.4 Hz, 1H, 11-H), 6.44 (d AB, J = 8.4 Hz, 1H, 12-H), 2.18 (td, J = 
12.6, 3.6 Hz, 1H, 5-Hax), 1.79 (td, J = 13.2, 3.9 Hz, 3-Hax), 1.71–1.42 (m, 3H, 5-Heq, 4-H), 1.49 
(s, 3H, 8-CH3), 1.26–1.18 (dm, J = 13.2 Hz, 1H, 3-Heq), 1.14 (d, J = 1 Hz, 3H, 6-CH3), 1.12 (s, 
3H, 2-CH3ax), 1.01 (s, 3H, 2-CH3eq). 13C NMR (CDCl3, 75 MHz): δ = 133.3 (d, C-12), 128.5 (d, 
C-11), 94.6 (s, C-8), 82.1 (s, C-1), 78.0 (s, C-6), 35.5 (s, C-2), 34.5 × 2 (t, C-3, C-5), 26.5 (q, C-
2-CH3eq), 25.4 (q, C-6-CH3), 24.3 (q, C-2-CH3ax), 20.8 (q, C-8-CH3), 19.2 (t, C-4). 
syn-2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodec-11-en-5-ol (1b). 1H NMR 
(CDCl3, 300 MHz): δ = 6.53 (d AB, J = 8.4 Hz, 1H, 11-H), 6.42 (d AB, J = 8.4 Hz, 1H, 12-H), 
3.72 (t, J = 2.9 Hz, 1H, 5-Heq), 3.54 (bs, 1H, OH), 2.00 (td, J = 13.0, 4.2 Hz, 1H, 3-Hax), 1.95–
1.68 (m, 2H, 4-H), 1.52 (s, 3H, 8-CH3), 1.08 (dt, J = 13.0, 3.9 Hz, 3-Heq), 1.08 (s, 3H, 6-CH3), 
1.07 (s, 3H, 2-CH3ax), 0.96 (s, 3H, 2-CH3eq). 13C NMR (CDCl3, 75 MHz): δ = 133.2 (d, C-12), 
128.9 (d, C-11), 94.8 (s, C-8), 82.8 (s, C-1), 78.4 (s, C-6), 71.1 (d, C-5), 35.1 (s, C-2), 28.8 (t, C-
3), 26.05 (q, C-2-CH3eq), 26.00 (q, C-2-CH3ax), 25.5 (t, C-4), 24.1 (q, C-6-CH3), 20.4 (q, C-8-
CH3). 
anti-2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodec-11-en-5-ol (1c). 1H NMR 
(CDCl3, 300 MHz): δ = 6.52 (d AB, J = 8.6 Hz, 11-H), 6.44 (d AB, J = 8.6 Hz, 12-H), 4.34 (dd, 
J = 12.1, 4.6 Hz, 1H, 5-Hax), 1.91 (td, J = 13.5, 4.4 Hz, 1H, 3-Hax), 1.89–1.81 (m, 1H, 4-Hax), 
1.62–1.50 (m, 1H, 4-Heq), 1.51 (s, 3H, 8-CH3), 1.32 (ddd, J = 14.0, 4.8, 3.1 Hz, 1H, 3-Heq), 1.12 
(s, 3H, 2-CH3ax), 1.07 (s, 3H, 6-CH3), 1.00 (s, 3H, 2-CH3eq). 13C NMR (CDCl3, 75 MHz): δ = 
133.3 (d, C-12), 128.6 (d, C-11), 94.9 (s, C-8), 83.1 (s, C-1), 80.8 (s, C-6), 73.7 (d, C-5), 35.5 (s, 
C-2), 33.6 (t, C-3), 26.7 (t, C-4), 26.0 (q, C-2-CH3eq), 24.5 (q, C-2-CH3ax), 20.7 (q, C-8-CH3), 
19.4 (q, C-6-CH3). 
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syn-2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodec-11-en-5-yl Acetate (1d). 1H 
NMR (CDCl3, 300 MHz): δ = 6.55 (d AB, J = 8.4 Hz, 1H, 11-H), 6.43 (d AB, J = 8.4 Hz, 1H, 
12-H), 5.12 (t, J = 3.0 Hz, 1H, 5-Heq), 2.18 (s, 3H, COCH3), 2.12 (td, J = 14.0, 4.3 Hz, 1H, 3-
Hax), 1.93 (tdd, J = 15.0, 4.0, 3.2 Hz, 1H, 4-Hax), 1.73 (ddt, J = 15.1, 4.5, 2.8 Hz, 1H, 4-Heq), 1.45 
(s, 3H, 8-CH3), 1.26–1.12 (m, 1H, 3-Heq), 1.17 (s, 3H, 6-CH3), 1.14 (s, 3H, 2-CH3ax), 1.04 (s, 3H, 
2-CH3eq). 13C NMR (CDCl3, 75 MHz): δ = 171.4 (s, COO), 133.3 (d, C-12), 128.6 (d, C-11), 
94.2 (s, C-8), 80.9 (s, C-1), 77.3 (s, C-6), 70.7 (d, C-5), 34.9 (s, C-2), 29.6 (t, C-3), 26.1 × 2 (q, 
C-2-CH3eq, C-6-CH3), 24.0 (q, C-2-CH3ax), 23.5 (t, C-4), 21.4 (q, COCH3), 20.5 (q, C-8-CH3). 
anti-2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodec-11-en-5-yl acetate (1e). 1H 
NMR (CDCl3, 300 MHz): δ = 6.50 (d AB, J = 8.5 Hz, 1H, 11-H), 6.45 (d AB, J = 8.5 Hz, 1H, 
12-H), 5.46 (dd, J = 12.0, 4.5 Hz, 1H, 5-Hax), 2.08 (s, 3H, COCH3), 2.05–1.85 (m, 2H, 3-Hax, 4-
Hax), 1.51 (td, J = 14.5, 4.2 Hz, 1H, 4-Heq), 1.47 (s, 3H, 8-CH3), 1.28 (dm, J = 13.8 Hz, 1H, 3-
Heq), 1.13 (s, 6H, 6-CH3, 2-CH3ax), 1.01 (s, 3H, 2-CH3eq). 13C NMR (CDCl3, 75 MHz): δ = 170.2 
(s, COO), 133.8 (d, C-12), 128.0 (d, C-11), 94.7 (s, C-8), 83.0 (s, C-1), 78.8 (s, C-6), 76.2 (d, C-
5), 35.3 (s, C-2), 33.2 (t, C-3), 26.0 (q, C-2-CH3eq), 24.9 (t, C-4), 24.3 (q, C-6-CH3), 21.3 (q, 
COCH3), 20.5 (q, C-8-CH3), 20.4 (q, C-2-CH3ax). 
2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodec-11-en-5-one (1f). 1H NMR (CDCl3, 
300 MHz): δ = 6.52 (d AB, J = 8.5 Hz, 1H, 11-H), 6.51 (d AB, J = 8.5 Hz, 1H, 12-H), 2.73 (ddd, 
J = 15.1, 13.5, 6.5 Hz, 1H, 4-Hax), 2.46 (ddd, J = 15.2, 5.1, 2.6 Hz, 1H, 4-Heq), 2.18 (td, J = 13.8, 
5.0 Hz, 1H, 3-Hax), 1.63 (ddd, J = 13.8, 6.6, 2.7 Hz, 1H, 3-Heq), 1.59 (s, 3H, 8-CH3), 1.36 (s, 3H, 
6-CH3), 1.26 (s, 3H, 2-CH3ax), 1.10 (s, 3H, 2-CH3eq). 13C NMR (CDCl3, 75 MHz): δ =  207.6 (s, 
C-5), 134.8 (d, C-12), 126.1 (d, C-11), 95.2 (s, C-8), 85.1 (s, C-1), 82.9 (s, C-6), 35.5 (s, C-2), 
34.7 (t, C-3), 34.5 (t, C-4), 25.5 (q, C-2-CH3eq), 24.4 × 2 (q, C-6-CH3, C-2-CH3ax), 20.4 (q, C-8-
CH3). 
2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodeca-4,11-diene (1g). 1H NMR (CDCl3, 
300 MHz): δ = 6.61 (d AB, J = 8.4 Hz, 1H, 11-H), 6.47 (d AB, J = 8.4 Hz, 1H, 12-H), 5.79–5.66 
(m, 2H, 5-H, 4-H), 2.34 (bd, J = 17.1 Hz, 1H, 3-Hα), 1.79 (dd, J = 18.1, 3.7 Hz, 1H, 3-Hβ), 1.53 
(s, 3H, 8-CH3), 1.22 (s, 3H, 6-CH3), 1.13 (s, 3H, 2-CH3ax), 1.10 (s, 3H, 2-CH3eq). 13C NMR 
(CDCl3, 75 MHz): δ = 133.3 (d, C-12), 129.1 (d, C-5), 127.4 (d, C-11), 125.4 (d, C-4), 95.5 (s, 
C-8), 81.7 (s, C-1), 77.1 (s, C-6), 37.3 (t, C-3), 33.9 (s, C-2), 27.5 (q, C-6-CH3), 27.2 (q, C-2-
CH3ax), 25.2 (q, C-2-CH3eq), 20.9 (q, C-8-CH3).  
2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodecane (2a). 1H NMR (CDCl3, 300 
MHz): δ = 2.21 (td, J = 13.9, 5.2 Hz, 1H, 5-Hax), 2.15–1.95 (m, 4H, 11-H, 12-H), 1.72 (td, J = 
13.2, 4.1 Hz, 1H, 3-Hax), 1.48–1.43 (m, 3H, 5-Heq, 4-H), 1.40 (s, 3H, 6-CH3), 1.26 (s, 3H, 8-
CH3), 1.12 (dm, J = 13.2 Hz, 1H, 3-Heq), 0.98 (s, 3H, 2-CH3ax), 0.96 (s, 3H, 2-CH3eq). 13C NMR 
(CDCl3, 75 MHz): δ = 96.7 (s, C-8), 80.6 (s, C-1), 77.9 (s, C-6), 37.2 (s, C-2), 36.4 (t, C-5), 35.7 
(t, C-3), 30.0 (t, C-12), 25.9 (q, C-2-CH3eq), 25.7 (q, C-6-CH3), 24.6 (q, C-2-CH3ax), 23.3 (q, C-8-
CH3), 19.7 (t, C-11), 19.2 (t, C-4). 
syn-2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodecan-5-ol (2b). 1H NMR (CDCl3, 
300 MHz): δ = 3.70 (bs, 1H, 5-Heq), 3.66 (bs, 1H, OH), 2.19–2.00 (m, 5H, 11-H, 12-H, 3-Hax), 
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1.88 (bddd, J = 14.6, 7.0, 3.2 Hz, 1H, 4-Heq), 1.72 (tdd, J = 14.6, 3.8, 2.5 Hz, 1H, 4-Hax), 1.39 (s, 
3H, 6-CH3), 1.37 (s, 3H, 8-CH3), 1.02 (s, 3H, 2-CH3ax), 1.01 (dt, J = 13.5, 3.6 Hz, 1H, 3-Heq), 
0.99 (s, 3H, 2-CH3eq). 13C NMR (CDCl3, 75 MHz): δ = 97.2 (s, C-8), 81.5 (s, C-1), 78.3 (s, C-6), 
73.0 (d, C-5), 36.8 (s, C-2), 29.8 (t, C-3), 29.6 (t, C-12), 26.0 (q, C-6-CH3), 25.6 (q, C-2-CH3eq), 
25.4 (t, C-4), 24.7 (q, C-2-CH3ax), 23.1 (q, C-8-CH3), 20.3 (t, C-11).  
anti-2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodecan-5-ol (2c). 1H NMR (CDCl3, 
300 MHz): δ = 4.36 (dd, J = 12.4, 4.6 Hz, 1H, 5-Hax), 2.15–1.74 (m, 6H, 11-H, 12-H, 4-Heq, 3-
Hax), 1.56–1.43 (m, 1H, 4-Hax), 1.35 (s, 3H, 6-CH3), 1.29 (s, 3H, 8-CH3), 1.23 (ddd, J = 14.1, 
4.5, 2.5 Hz, 1H, 3-Heq), 1.00 (s, 3H, 2-CH3ax), 0.95 (s, 3H, 2-CH3eq). 13C NMR (CDCl3, 75 
MHz): δ = 97.1 (s, C-8), 81.8 (s, C-1), 80.8 (s, C-6), 74.1 (d, C-5), 37.3 (s, C-2), 34.4 (t, C-3), 
29.7 (t, C-12), 26.4 (t, C-4), 25.5 (q, C-2-CH3eq), 24.8 (q, C-2-CH3ax), 23.2 (q, C-8-CH3), 20.3 (t, 
C-11), 19.3 (q, C-6-CH3).  
syn-2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodecan-5-yl Acetate (2d). 1H NMR 
(CDCl3, 300 MHz): δ = 5.05 (t, J = 3.0 Hz, 1H, 5-Heq), 2.16 (s, 3H, COCH3), 2.20–1.66 (m, 7H, 
11-H, 12-H, 4-H, 3-Hax), 1.43 (s, 3H, 6-CH3), 1.23 (s, 3H, 8-CH3), 1.04 (t, J = 3.2 Hz, 1H, 3-
Heq), 1.02 (s, 3H, 2-CH3ax), 1.01 (s, 3H, 2-CH3eq). 13C NMR (CDCl3, 75 MHz): δ = 171.3 (s, 
CO), 96.2 (s, C-8), 79.5 (s, C-1), 77.0 (s, C-6), 72.6 (d, C-5), 36.6 (s, C-2), 30.5 (t, C-3), 29.8 (t, 
C-12), 26.3 (q, C-6-CH3), 25.6 (q, C-2-CH3eq), 24.5 (q, C-2-CH3ax), 23.5 (t, C-4), 23.0 (q, C-8-
CH3), 21.5 (q, COCH3), 20.4 (t, C-11).   
anti-2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodecan-5-yl Acetate (2e). 1H NMR 
(CDCl3, 300 MHz): δ = 5.51 (dd, J = 12.3, 4.8 Hz, 1H, 5-Hax), 2.09 (s, 3H, COCH3), 2.15–1.85 
(m, 6H, 11-H, 12-H, 4-Heq, 3-Hax), 1.50–1.38 (m, 1H, 4-Hax), 1.41 (s, 3H, 6-CH3), 1.25 (s, 3H, 8-
CH3), 1.24–1.17 (m, 1H, 3-Heq), 1.01 (s, 3H, 2-CH3ax), 0.97 (s, 3H, 2-CH3eq). 13C NMR (CDCl3, 
75 MHz): δ = 170.4 (s, CO), 96.9 (s, C-8), 81.9 (s, C-1), 79.0 (s, C-6), 76.5 (d, C-5), 37.1 (s, C-
2), 34.0 (t, C-3), 29.7 (t, C-12), 25.5 (q, C-2-CH3eq), 24.9 (t, C-4), 24.5 (q, C-2-CH3ax), 23.0 (q, 
C-8-CH3), 21.3 (q, COCH3), 20.3 (q, C-6-CH3), 20.0 (t, C-11).  
2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodecan-5-one (2f). 1H NMR (CDCl3, 300 
MHz): δ = 2.66–2.49 (m, 2H, 4-H), 2.21–2.12 (m, 2H, 11-H), 2.11–1.98 (m, 3H, 12-H, 3-Heq), 
1.61 (ddd, J = 13.9, 11.5, 5.7 Hz, 1H, 3-Hax), 1.50 (s, 3H, 6-CH3), 1.38 (s, 3H, 8-CH3), 1.20 (s, 
3H, 2-CH3ax), 1.06 (s, 3H, 2-CH3eq). 13C NMR (CDCl3, 75 MHz): δ = 208.8 (s, C-5), 98.1 (s, C-
8), 84.0 (s, C-1), 82.3 (s, C-6), 36.9 (s, C-2), 34.8 (t, C-3), 34.6 (t, C-4), 29.7 (t, C-12), 25.2 (q, 
C-2-CH3ax), 24.8 (q, C-2-CH3eq), 23.8 (q, C-6-CH3), 22.8 (q, C-8-CH3), 19.8 (t, C-11).  
2,2,6,8-Tetramethyl-7,9,10-trioxatricyclo[6.2.2.01,6]dodec-4-ene (2g). 1H NMR (CDCl3, 300 
MHz): δ = 5.69 (ddd, J = 10.3, 4.7, 2.1 Hz, 1H, 4-H), 5.59 (dd, J = 10.3, 2.7 Hz, 1H, 5-H), 2.31 
(bd, J = 18.0 Hz, 1H, 3-Hβ), 2.26–2.02 (m, 4H, 11-H, 12-H), 1.63 (dd, J = 18.0, 4.6 Hz, 1H, 3-
Hα), 1.47 (s, 3H, 6-CH3), 1.32 (s, 3H, 8-CH3), 1.05 (s, 3H, 2-CH3ax), 1.02 (s, 3H, 2-CH3eq). 13C 
NMR (CDCl3, 75 MHz): δ = 130.4 (d, C-5), 125.2 (d, C-4), 98.2 (s, C-8), 80.3 (s, C-1), 75.9 (s, 
C-6), 37.2 (t, C-3), 35.5 (s, C-2), 30.0 (t, C-12), 26.6 (q, C-6-CH3), 26.3 (q, C-2-CH3eq), 24.6 (q, 
C-2-CH3ax), 23.4 (q, C-8-CH3), 19.6 (t, C-11).  
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2,2,6,8-Tetramethyl-7,11-dioxatricyclo[6.2.1.01,6]undecane (3a). 1H NMR (CDCl3, 300 MHz): 
δ = 1.94–1.43 (m, 8H, 10-H, 9-H, 5-H, 4-Heq, 3-Hax), 1.54 (s, 3H, 8-CH3), 1.37 (s, 3H, 6-CH3), 
1.36 (tt, J = 13.2, 3.0 Hz, 1H, 4-Hax), 1.32–1.25 (dm, J = 14.5 Hz, 1H, 3-Heq), 1.08 (s, 3H, 2-
CH3eq), 0.96 (s, 3H, 2-CH3ax). 13C NMR (CDCl3, 75 MHz): δ = 107.4 (s, C-8), 92.0 (s, C-1), 81.5 
(s, C-6), 39.1 (t, C-3), 37.8 (t, C-5), 37.4 (t, C-12), 34.3 (s, C-2), 26.0 (q, C-2-CH3eq), 25.0 (t, C-
11), 24.0 (q, C-2-CH3ax), 22.9 (q, C-6-CH3), 19.7 (q, C-8-CH3), 19.6 (t, C-4).  
syn-2,2,6,8-Tetramethyl-7,11-dioxatricyclo[6.2.1.01,6]undecan-5-ol (3b). 1H NMR (CDCl3, 
300 MHz): δ = 3.44 (bs, 1H, 5-Heq), 2.96 (bs, 1H, OH), 1.98 (td, J = 13.8, 3.6 Hz, 1H, 3-Hax), 
1.91–1.52 (m, 6H, 10-H, 9-H, 4-H), 1.53 (s, 3H, 8-CH3), 1.27 (s, 3H, 6-CH3), 1.04 (dt, J = 13.8, 
3.3 Hz, 1H, 3-Heq), 1.02 (s, 3H, 2-CH3eq), 0.91 (s, 3H, 2-CH3ax). 13C NMR (CDCl3, 75 MHz): δ = 
107.9 (s, C-8), 93.6 (s, C-1), 81.3 (s, C-6), 72.9 (d, C-5), 36.7 (t, C-9), 33.6 (s, C-2), 30.4 (t, C-
3), 25.8 (q, C-2-CH3eq), 25.6 (t, C-4), 25.5 (t, C-10), 24.1 (q, C-2-CH3ax), 22.6 (q, C-6-CH3), 18.9 
(q, C-8-CH3).  
anti-2,2,6,8-Tetramethyl-7,11-dioxatricyclo[6.2.1.01,6]undecan-5-ol (3c). 1H NMR (CDCl3, 
300 MHz): δ = 3.86 (dd, J = 12.3, 4.2 Hz, 1H, 5-Hax), 2.01–1.60 (m, 6H, 10-H, 9-H, 4-Heq, 3-
Hax), 1.54 (s, 3H, 8-CH3), 1.44 (td, J = 12.8, 3.1 Hz, 1H, 4-Hax), 1.37 (dt, J = 12.9, 3.2 Hz, 1H, 3-
Heq), 1.31 (s, 3H, 6-CH3), 1.07 (s, 3H, 2-CH3eq), 0.96 (s, 3H, 2-CH3ax). 13C NMR (CDCl3, 75 
MHz): δ = 108.3 (s, C-8), 93.5 (s, C-1), 85.4 (s, C-6), 76.5 (d, C-5), 37.2 (s, C-9), 36.1 (t, C-3), 
34.3 (s, C-2), 26.8 (t, C-4), 25.8 (t, C-10), 25.7 (q, C-2-CH3eq), 24.0 (q, C-2-CH3ax), 19.7 (q, C-8-
CH3), 15.1 (q, C-6-CH3).  
syn-2,2,6,8-Tetramethyl-7,11-dioxatricyclo[6.2.1.01,6]undec-5-yl Acetate (3d). 1H NMR 
(CDCl3, 300 MHz): δ = 4.82 (t, J = 3.0 Hz, 1H, 5-Heq), 2.12 (s, 3H, COCH3), 2.05–1.96 (m, 1H, 
3-Hax), 1.92–1.60 (m, 6H, 10-H, 9-H, 4-H), 1.52 (s, 3H, 8-CH3), 1.39 (s, 3H, 6-CH3), 1.36 (dt, J 
= 13.4, 3.3 Hz, 1H, 3-Heq), 1.12 (s, 3H, 2-CH3eq), 0.99 (s, 3H, 2-CH3ax). 13C NMR (CDCl3, 75 
MHz): δ = 170.4 (s, CO), 107.5 (s, C-8), 91.9 (s, C-1), 79.7 (s, C-6), 73.4 (d, C-5), 37.1 (t, C-9), 
33.6 (s, C-2), 31.1 (t, C-3), 25.8 (q, C-2-CH3eq), 25.4 (t, C-10), 23.8 (t, C-4), 23.7 (q, C-2-CH3ax), 
23.2 (q, C-6-CH3), 21.5 (q, COCH3), 18.9 (q, C-8-CH3).  
anti-2,2,6,8-Tetramethyl-7,11-dioxatricyclo[6.2.1.01,6]undec-5-yl Acetate (3e). 1H NMR 
(CDCl3, 300 MHz): δ = 5.00 (dd, J = 12.3, 4.2 Hz, 1H, 5-Hax), 2.06 (s, 3H, COCH3), 2.01–1.59 
(m, 6H, 10-H, 9-H, 4-Heq, 3-Hax), 1.54 (s, 3H, 8-CH3), 1.48–1.40 (m, 1H, 4-Hax), 1.38 (s, 3H, 6-
CH3), 1.35–1.31 (m, 1H, 3-Heq), 1.08 (s, 3H, 2-CH3eq), 0.97 (s, 3H, 2-CH3ax). 13C NMR (CDCl3, 
75 MHz): δ = 170.4 (s, CO), 108.4 (s, C-8), 93.7 (s, C-1), 83.3 (s, C-6), 78.7 (d, C-5), 37.2 (t, C-
9), 35.6 (t, C-3), 34.1 (s, C-2), 25.6 (q, C-2-CH3eq), 25.4 (C-10), 24.7 (t, C-4), 23.8 (q, C-2-
CH3ax), 21.3 (q, COCH3), 19.4 (q, C-8-CH3), 16.2 (q, C-6-CH3).  
2,2,6,8-Tetramethyl-7,11-dioxatricyclo[6.2.1.01,6]undecan-5-one (3f). 1H NMR (CDCl3, 300 
MHz): δ = 2.63 (td, J = 14.7, 5.7 Hz, 1H, 4-Hax), 2.35 (ddd, J = 14.7 3.9, 2.7 Hz, 1H, 4-Heq), 2.09 
(td, J = 14.7, 3.9 Hz, 1H, 3-Hax), 2.01–1.64 (m, 4H, 10-H, 9-H), 1.63 (ddd, J = 13.7, 5.7, 2.8 Hz, 
1H, 3-Heq), 1.55 (s, 3H, 8-CH3), 1.43 (s, 3H, 6-CH3), 1.19 (s, 3H, 2-CH3ax), 1.15 (s, 3H, 2-
CH3eq). 13C NMR (CDCl3, 75 MHz): δ = 210.6 (s, C-5), 107.9 (s, C-8), 95.5 (s, C-1), 85.5 (s, C-
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6), 37.4 (t, C-9), 36.4 (t, C-3), 35.2 (t, C-4), 33.9 (s, C-2), 25.2 (q, C-2-CH3eq), 24.3 (t, C-10), 
22.9 (q, C-2-CH3ax), 20.1 (q, C-6-CH3), 18.7 (q, C-8-CH3).  
2,2,6,8-Tetramethyl-7,11-dioxatricyclo[6.2.1.01,6]undec-4-ene (3g). 1H NMR (CDCl3, 300 
MHz): δ = 5.53 (ddd, J = 10.2, 5.4, 2.1 Hz, 1H, 4-H), 5.36 (dd, J = 10.3, 3.0 Hz, 1H, 5-H), 2.29 
(bdt, J = 17.4, 2.2 Hz, 1H, 3-Hβ), 2.00–1.76 (m, 4H, 10-H, 9-H), 1.74 (dd, J = 17.4, 5.4 Hz, 1H, 
3-Hα), 1.52 (s, 3H, 8-CH3), 1.37 (s, 3H, 6-CH3), 1.13 (s, 3H, 2-CH3eq), 0.97 (s, 3H, 2-CH3ax). 13C 
NMR (CDCl3, 75 MHz): δ = 131.1 (d, C-5), 123.6 (d, C-4), 106.7 (s, C-8), 91.5 (s, C-1), 79.2 (s, 
C-6), 37.6 (s, C-3), 37.3 (t, C-9), 33.1 (s, C-2), 25.2 (q, C-2-CH3eq), 24.15 (q, C-6-CH3), 24.12 
(q, C-2-CH3ax), 23.9 (t, C-10), 19.4 (q, C-8-CH3). 
 
 
Supplementary Material  
 
Table of 13C NMR chemical shifts and assignments for compounds 1a–g, 2a–g and 3a–g. 1H 
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